FENC 10-Q: SEC filing

Fennec Pharmaceuticals

Filed with the SEC on · accession 0001104659-26-126203

FENC filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. Fennec Pharmaceuticals filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, equity compensation activity, and related disclosures.

Summary of the filing

Fennec Pharmaceuticals filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, equity compensation activity, and related disclosures. No major corporate events such as executive changes, acquisitions, or guidance revisions were announced.

Key details

FilerFennec Pharmaceuticals Inc.

✦ Ask GOAX AI about this filing — what it means for FENC, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for FENC?

Click here

Frequently asked questions

What did FENC file with the SEC on Nov 12, 2026?

FENC filed a 10-Q (SEC filing). Fennec Pharmaceuticals filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, equity compensation activity, and related disclosures. No major corporate events such as executive changes, acquisitions, or guidance revisions were announced.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

Other FENC SEC filings

Get alerts when FENC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days